SNCA and Parkinson disease: The downregulation of miR-1, miR-153, and miR-195, which are frequently observed in PD serum, cannot suppress the expression of α-synuclein (SNCA), as these miRNAs directly target SNCA mRNA, leading to increased α-synuclein aggregation and subsequent microglia activation.